BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 15833290)

  • 21. Simple and simultaneous determination of the hiv-protease inhibitors amprenavir, atazanavir, indinavir, lopinavir, nelfinavir, ritonavir and saquinavir plus M8 nelfinavir metabolite and the nonnucleoside reverse transcriptase inhibitors efavirenz and nevirapine in human plasma by reversed-phase liquid chromatography.
    Poirier JM; Robidou P; Jaillon P
    Ther Drug Monit; 2005 Apr; 27(2):186-92. PubMed ID: 15795650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-performance liquid chromatography assay for the quantification of HIV protease inhibitors and non-nucleoside reverse transcriptase inhibitors in human plasma.
    Rezk NL; Tidwell RR; Kashuba AD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jun; 805(2):241-7. PubMed ID: 15135096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantification of 8 HIV-protease inhibitors and 2 nonnucleoside reverse transcriptase inhibitors by ultra-performance liquid chromatography with diode array detection.
    Elens L; Veriter S; Di Fazio V; Vanbinst R; Boesmans D; Wallemacq P; Haufroid V
    Clin Chem; 2009 Jan; 55(1):170-4. PubMed ID: 19028822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Plasmatic dosage of antiretroviral drugs by high performance liquid chromathography ].
    Titier K; Lagrange F; Péhourcq F; Edno-Mcheik L; Moore N; Molimard M
    Therapie; 2002; 57(2):169-74. PubMed ID: 12185966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantification of the HIV-integrase inhibitor raltegravir and detection of its main metabolite in human plasma, dried blood spots and peripheral blood mononuclear cell lysate by means of high-performance liquid chromatography tandem mass spectrometry.
    Ter Heine R; Hillebrand MJ; Rosing H; van Gorp EC; Mulder JW; Beijnen JH; Huitema AD
    J Pharm Biomed Anal; 2009 Feb; 49(2):451-8. PubMed ID: 19128911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electrospray tandem mass spectroscopic characterisation of 18 antiretroviral drugs and simultaneous quantification of 12 antiretrovirals in plasma.
    Gehrig AK; Mikus G; Haefeli WE; Burhenne J
    Rapid Commun Mass Spectrom; 2007; 21(16):2704-16. PubMed ID: 17639576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiretrovirals: simultaneous determination of five protease inhibitors and three nonnucleoside transcriptase inhibitors in human plasma by a rapid high-performance liquid chromatography--mass spectrometry assay.
    Villani P; Feroggio M; Gianelli L; Bartoli A; Montagna M; Maserati R; Regazzi MB
    Ther Drug Monit; 2001 Aug; 23(4):380-8. PubMed ID: 11477320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-performance liquid chromatographic assay to determine the plasma levels of HIV-protease inhibitors (amprenavir, indinavir, nelfinavir, ritonavir and saquinavir) and the non-nucleoside reverse transcriptase inhibitor (nevirapine) after liquid-liquid extraction.
    Dailly E; Thomas L; Kergueris MF; Jolliet P; Bourin M
    J Chromatogr B Biomed Sci Appl; 2001 Jul; 758(2):129-35. PubMed ID: 11486821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HPLC-MS method for the quantification of nine anti-HIV drugs from dry plasma spot on glass filter and their long term stability in different conditions.
    D'Avolio A; Simiele M; Siccardi M; Baietto L; Sciandra M; Bonora S; Di Perri G
    J Pharm Biomed Anal; 2010 Sep; 52(5):774-80. PubMed ID: 20236784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An isocratic liquid chromatography method for determining HIV non-nucleoside reverse transcriptase inhibitor and protease inhibitor concentrations in human plasma.
    Weller DR; Brundage RC; Balfour HH; Vezina HE
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 848(2):369-73. PubMed ID: 17081812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantification of seven nucleoside/nucleotide reverse transcriptase inhibitors in human plasma by high-performance liquid chromatography with tandem mass-spectrometry.
    Le Saux T; Chhun S; Rey E; Launay O; Weiss L; Viard JP; Pons G; Jullien V
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Apr; 865(1-2):81-90. PubMed ID: 18325857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of a rapid and selective method for the simultaneous determination of protease inhibitors, lopinavir and ritonavir in human plasma by UPLC-ESI-MS/MS for bioequivalence study in Indian subjects.
    Yadav M; Rao R; Kurani H; Singhal P; Goswami S; Shrivastav PS
    J Pharm Biomed Anal; 2009 May; 49(4):1115-22. PubMed ID: 19282124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of an electrospray ionization LC-MS/MS method for quantitative analysis of raltegravir, etravirine, and 9 other antiretroviral agents in human plasma samples.
    Quaranta S; Woloch C; Paccou A; Giocanti M; Solas C; Lacarelle B
    Ther Drug Monit; 2009 Dec; 31(6):695-702. PubMed ID: 19865000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-performance liquid chromatographic method for the simultaneous determination of the six HIV-protease inhibitors and two non-nucleoside reverse transcriptase inhibitors in human plasma.
    Titier K; Lagrange F; Péhourcq F; Edno-Mcheik L; Moore N; Molimard M
    Ther Drug Monit; 2002 Jun; 24(3):417-24. PubMed ID: 12021635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A LC-tandem MS assay for the simultaneous measurement of new antiretroviral agents: Raltegravir, maraviroc, darunavir, and etravirine.
    Fayet A; Béguin A; Zanolari B; Cruchon S; Guignard N; Telenti A; Cavassini M; Günthard HF; Buclin T; Biollaz J; Rochat B; Decosterd LA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Apr; 877(11-12):1057-69. PubMed ID: 19332396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and validation of a liquid chromatographic/tandem mass spectrometric assay for the quantitation of nucleoside HIV reverse transcriptase inhibitors in biological matrices.
    Compain S; Schlemmer D; Levi M; Pruvost A; Goujard C; Grassi J; Benech H
    J Mass Spectrom; 2005 Jan; 40(1):9-18. PubMed ID: 15643642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct and fast determination of antiretroviral drugs by automated online solid-phase extraction-liquid chromatography-tandem mass spectrometry in human plasma.
    Koal T; Sibum M; Koster E; Resch K; Kaever V
    Clin Chem Lab Med; 2006; 44(3):299-305. PubMed ID: 16519602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HPLC-MS method for the simultaneous quantification of the new HIV protease inhibitor darunavir, and 11 other antiretroviral agents in plasma of HIV-infected patients.
    D'Avolio A; Siccardi M; Sciandra M; Baietto L; Bonora S; Trentini L; Di Perri G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Nov; 859(2):234-40. PubMed ID: 17964231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simultaneous determination of the six HIV protease inhibitors (amprenavir, indinavir, lopinavir, nelfinavir, ritonavir, and saquinavir) plus M8 nelfinavir metabolite and the nonnucleoside reverse transcription inhibitor efavirenz in human plasma by solid-phase extraction and column liquid chromatography.
    Poirier JM; Robidou P; Jaillon P
    Ther Drug Monit; 2002 Apr; 24(2):302-9. PubMed ID: 11897976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determination of a novel substance P inhibitor in human plasma by high-performance liquid chromatography with atmospheric pressure chemical ionization mass spectrometric detection using single and triple quadrupole detectors.
    Constanzer ML; Chavez-Eng CM; Dru J; Kline WF; Matuszewski BK
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Aug; 807(2):243-50. PubMed ID: 15203036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.